REANNZ develops and supports a range of products and services to support the specialist needs of our members in the R&E and innovation community.
We operate NZ's national research and education network and seamlessly connect with 120+ networks globally to enable researchers to collaborate.
REANNZ is proud to support the specialist needs of our members from NZ's research, education and innovation community.
Find out more about who REANNZ is, what we do and the people that operate New Zealand’s national research and education network.
Researcher Chun Vong is using REANNZ HPC resources and deep learning approaches to study and characterise brain tumour microenvironments.
Glioblastoma (GBM) is the most common and aggressive form of high-grade brain tumour (HGBT), with a median survival of just 15 months. Accurate pathological diagnosis is critical for prognosis and treatment planning.
Traditionally, histopathological analysis, such as hematoxylin and eosin (H&E) staining, has been central to diagnosis. Over time, ancillary immunohistochemistry (IHC) and advances in transcriptomic and methylomic technologies have provided unprecedented tumour heterogeneity data, enhancing diagnostic precision.
However, these advanced omics-based methods are often inaccessible due to high costs and the need for specialised infrastructure. To bridge this gap, researchers are increasingly turning to digital pathology platforms that integrate rich biological data with routinely available histological images.
At the University of Auckland, researcher Chun Vong is developing a data-driven multiscale analysis platform for HGBT that leverages deep learning to characterise tumour microenvironments.
By mapping molecular insights onto histological features, the platform aims to uncover prognostic biomarkers and guide personalised therapeutic strategies—without requiring expensive omics testing for every patient.
This ambitious project relies on computationally intensive deep learning models, demanding significant memory, parallel processing power, and efficient pipeline orchestration.
An example of the images generated from the analysis platform University of Auckland Research Chun Vong is developing.
The development of Chun’s multiscale platform faces several technical hurdles:
Without expert support, navigating these challenges could delay progress and limit scalability.
Chris Scott and Maxime Rio, Research Software Engineers working at New Zealand eScience Infrastructure at the time, collaborated closely with Chun to optimise and deploy his analysis pipeline on the national HPC platform.
While Chun led the development of the scientific pipeline – drawing on his strong programming background – Chris and Maxime provided critical expertise in HPC best practices, containerisation, and scalable computing:
Thanks to the collaboration with Chris and Maxime, the project achieved the following outcomes:
As a result, Chun can continue to develop his HGBT deep learning platform using powerful GPUs – accelerating model development and validation.
This project required scaling of our model training and optimisations for us to train many models at the same time, efficiently. We sought the consultancy’s help with this, and they were instrumental in automating and setting up the optimisations runs for my models. In the end, I was able to scale our training and was able to optimised over 100 models effectively during my PhD candidature. Without them, none of the optimised modelling would have been possible.
Chun Kiet Vong, Auckland Bioengineering Institute, University of Auckland
Find anything about our products, services, and more. Enter a query in the search input above.